Loading clinical trials...

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring | Clinical Trials | Clareo Health

COMPLETED

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

NCT04362553•Northwestern University

View on ClinicalTrials.gov

Summary

Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Patient's aged 18-65
•2. Patient's scheduled to undergo a Trans-thoracic Echocardiogram (TTE) in an outpatient cardiology clinic or admitted to the Cardiac Care Unit with a swan ganz catheter in place for continuous invasive hemodynamic monitoring

Exclusion Criteria

•1. Patient's with fragile skin or skin conditions that would prevent them from having a sensor placed
•2. Patients undergoing exercise or drug induced cardiac stress test
•3. Patients with a visible wound at site of sensor placement 3.4. Patients with structural or functional limitations to peripheral blood flow (known upper extremity peripheral arterial disease, use of vasopressors etc.).

Locations (1)

Northwestern Memorial Hospital

Chicago, Illinois, United States

Key Dates

Start Date

June 1, 2020

Primary Completion Date

November 23, 2020

Completion Date

September 5, 2022

Last Updated

September 28, 2022

Enrollment

ACTUAL participants

Conditions

Congestive Heart Failure

Interventions

wearable vital signs sensor

DEVICE

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

NCT05507879

Breast CarcinomaCardiomyopathy+1 more

View study

RECRUITINGNA

Stress and Congestive Heart Failure

NCT04551560

Congestive Heart Failure

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 28, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

Inclusion Criteria

Exclusion Criteria

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

Stress and Congestive Heart Failure

Eat Well Heart Failure

Peritoneal Ultrafiltration in Cardio Renal Syndrome.

SyncAV Post-Market Trial

Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study